Ryu Hyunjin, Hong Yeji, Kang Eunjeong, Kang Minjung, Kim Jayoun, Oh Yun Kyu, Yang Soo Jin, Yang Yun Jung, Park Sue K, Chung Wookyung, Chae Dong-Wan, Sung Su Ah, Ahn Curie, Oh Kook-Hwan
Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Rehabilitation Medical Research Center, Korea Workers' Compensation and Welfare Service Incheon Hospital, Incheon, Republic of Korea.
J Ren Nutr. 2021 Nov;31(6):569-578. doi: 10.1053/j.jrn.2021.01.026. Epub 2021 Mar 23.
Both obesity and being underweight are risk factors for adverse outcomes in chronic kidney disease (CKD) patients. However, the effects of longitudinal weight changes on patients with predialysis CKD have not yet been studied. In this study, we analyzed the effects of weight change over time on the adverse outcomes in predialysis CKD population.
Longitudinal data from a multicenter prospective cohort study (KNOW-CKD) were analyzed. In a total of 2,022 patients, the percent weight change per year were calculated using regression analysis and the study subjects were classified into five categories: group 1, ≤ -5%/year; group 2, -5< to ≤ -2.5%/year; group 3, -2.5< to <2.5%/year; group 4, 2.5≤ < 5%/year; and group 5, ≥5%/year. The incidences of end-stage renal disease (ESRD) and the composite outcome of cardiovascular disease (CVD) and death were calculated in each group and compared to group 3 as reference.
During a median 4.4 years of follow-up, 414 ESRD, and 188 composite of CVD and mortality events occurred. Both weight gain and loss were independent risk factors for adverse outcomes. There was a U-shaped correlation between the degree of longitudinal weight change and ESRD (hazard ratio 3.61, 2.15, 1.86 and 3.66, for group 1, 2, 4 and 5, respectively) and composite of CVD and death (hazard ratio 2.92, 2.15, 1.73 and 2.54, respectively), when compared to the reference group 3. The U-shape correlation was most prominent in the subgroup of estimated glomerular filtration rate <45 mL/min/1.73 m.
Both rapid weight gain and weight loss are associated with high risk of adverse outcomes, particularly in the advanced CKD.
肥胖和体重过轻均为慢性肾脏病(CKD)患者不良结局的危险因素。然而,透析前CKD患者体重的纵向变化对其影响尚未得到研究。在本研究中,我们分析了随时间的体重变化对透析前CKD人群不良结局的影响。
分析一项多中心前瞻性队列研究(KNOW-CKD)的纵向数据。总共2022例患者,采用回归分析计算每年的体重变化百分比,并将研究对象分为五类:第1组,≤-5%/年;第2组,-5%<至≤-2.5%/年;第3组,-2.5%<至<2.5%/年;第4组,2.5%≤至<5%/年;第5组,≥5%/年。计算每组终末期肾病(ESRD)的发生率以及心血管疾病(CVD)和死亡的复合结局,并与作为参照的第3组进行比较。
在中位4.4年的随访期内,发生了414例ESRD以及188例CVD和死亡的复合事件。体重增加和减轻均为不良结局的独立危险因素。与参照组第3组相比,纵向体重变化程度与ESRD(第1、2、4和5组的风险比分别为3.61、2.15、1.86和3.66)以及CVD和死亡的复合结局(风险比分别为2.92、2.15、1.73和2.54)之间呈U形关联。这种U形关联在估计肾小球滤过率<45 mL/min/1.73 m²的亚组中最为显著。
体重快速增加和减轻均与不良结局的高风险相关,尤其是在晚期CKD患者中。